Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil combined with remimazolam for painless bronchoscopy in elderly patients
ChiCTR2600135327Phase 4Recruiting
- Sponsor
- Dazhou Dachuan District People's Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil, remimazolam and midazolam (2 arms), sponsored by Dazhou Dachuan District People's Hospital. Primary endpoint: hemodynamic parameters. Started Mar 2025; status: recruiting.
02
Drugs
alfentanilremimazolammidazolam
Beyond the preview
Go deeper on ChiCTR2600135327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135327.